Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-03-25 | Myla P. Lai-Goldman, M.D Age: 56 Director since 2014 Committees: Innovation & Technology 2013 Non-Employee Director Compensation Myla P. Lai-Goldman Fees Earned or Paid in Cash: 0 Stock Awards: 130,015 All Other Compensation: 0 Total: 130,015 |
| 2015-03-24 | Myla P. Lai-Goldman, M.D Age: 57 Committees: Innovation & Technology, Succession Planning 2014 Non-Employee Director Compensation: Total $188,968 Dr. Lai-Goldman is Chief Executive Officer and President of GeneCentric Diagnostics, Inc. |
| 2016-03-23 | Myla P. Lai-Goldman, M.D Age: 58 Director since 2014 Committees: Innovation & Technology Dr. Lai-Goldman is Chief Executive Officer and President of GeneCentric Diagnostics, Inc. ... 2015 Non-Employee Director Compensation ... Myla P. Lai-Goldman Fees Earned or Paid in Cash: 80,000 Stock Awards: 130,000 All Other Compensation: 1,716 Total: 211,716 |
| 2017-03-22 | Myla P. Lai-Goldman, M.D. Age: 59 Director since 2014 Committees: Innovation & Technology Finance Dr. Lai-Goldman has been Chief Executive Officer and President of GeneCentric Diagnostics, Inc. since June 2011. ... 2016 Non-Employee Director Compensation Myla P. Lai-Goldman Fees Earned or Paid in Cash: 77,500 Stock Awards: 160,000 All Other Compensation: 3,363 Total: 240,863 |
| 2018-03-21 | Myla P. Lai-Goldman, M.D. Age: 60 Director since 2014 Committees: Finance Innovation & Technology Dr. Lai-Goldman has been Chief Executive Officer and President of GeneCentric Therapeutics, Inc. – a precision medicine company – since June 2011 and serves as director for the company. 2017 Non-Employee Director Compensation Myla P. Lai-Goldman Fees Earned or Paid in Cash ($): 80,000 Stock Awards ($): 159,976 All Other Compensation ($): 3,632 Total ($): 243,608 |
| 2019-03-22 | Dr. Lai-Goldman is the Executive Chair of GeneCentric Therapeutics, Inc... Dr. Lai-Goldman is Board-certified in anatomic and clinical pathology... She brings her unique perspective as both a physician, researcher and corporate executive to the Board as Chair of the Innovation and Technology Committee and as a member of the Finance Committee. |
| 2020-03-25 | Dr. Lai-Goldman is the Executive Chair of GeneCentric Therapeutics, Inc... She brings her unique perspective as both a physician, researcher and corporate executive to the Board as Chair of the Innovation and Technology Committee and as a member of the Finance Committee. |
| 2021-03-24 | Dr. Lai-Goldman is the Executive Chair of GeneCentric Therapeutics, Inc... She brings her unique perspective as both a physician, researcher and corporate executive to the Board as Chair of the Innovation and Technology Committee and as a member of the Finance Committee. 2020 Non-Employee Director Compensation: $302,922. |
| 2022-04-14 | Dr. Lai-Goldman is a recognized author and speaker on clinical diagnostics and has substantial leadership experience. |
| 2023-03-15 | Myla P. Lai-Goldman, M.D., 65 Independent Chair and Former Chief Executive Officer and President GeneCentric Therapeutics, Inc., a precision medicine company 2011-present Director Since 2014 Committees Finance Innovation & Technology (Chair) 2022 Non-Employee Director Compensation ... Myla P. Lai-Goldman 105,000 Fees Earned or Paid in Cash 190,055 Stock Awards 13,820 All Other Compensation 308,875 Total |
Data sourced from SEC filings. Last updated: 2025-08-30